Not provided
Not provided
Not provided
Not provided
Not provided
This study was terminated by the Principal Investigator
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Aquaceutica Group | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study investigates the effects of daily use of lithia water on blood tests of neuronal oxidative stress, mood, and well-being. Lithia water is a type of pure spring water containing trace levels of lithium, which is a naturally occurring mineral. Neuronal oxidative stress is caused by normal chemical reactions in the human body that sometimes result in damage to brain cells. Participation in this study will last for 8 weeks and includes daily use of study water for drinking.
The primary objective of this pilot study is to test the hypothesis that, in healthy male participants, daily use of lithia water will improve neurogenesis and antioxidant capacity as measured by serum levels of brain-derived neurotrophic factor (BDNF) and oxidative stress markers. Secondary objectives will include examining self-reported changes in mood, cognition, and well-being.
There is some indication from epidemiological studies that areas with trace concentrations of lithium in drinking water have lower rates of suicide. This study will evaluate the effects of drinking EDJ (pronounced "edge") lithia spring water (which comes from a natural spring in the Rocky Mountains and contains trace amounts [0.68 mg/litre] of lithium) for 4 weeks, compared to drinking commercially available bottled water (which contains no lithium at all) for 4 weeks.
This pilot study has been designed as an 8-week randomized, counterbalanced, crossover study in 15 healthy male participants. Eligible participants will use lithia water or control water for daily ingestion for 4 weeks, then cross over to the other condition for another 4 weeks. At baseline and after each 4-week condition, participants will complete self-report questionnaires of mood, cognition and well-being, and blood samples will be assayed for BDNF and oxidative stress protein markers.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Lithia spring water | Experimental | Lithia water (active) for 4 weeks then placebo water for 4 weeks |
|
| Natural spring water | Placebo Comparator | Placebo water for 4 weeks then lithia water (active) for 4 weeks |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Lithia water | Dietary Supplement | Oral intake of approximately 2 litres (2L) daily for 4 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change from Baseline in BDNF levels at 4 weeks | Blood samples will be assayed for brain-derived neurotrophic factor | Baseline, Wk 4, Wk 8 |
| Measure | Description | Time Frame |
|---|---|---|
| Standardized, validated questionnaires querying mood and quality of life | Baseline, Wk 4, Wk 8 | |
| Standardized, validated questionnaires regarding cognitive functioning | Baseline, Wk 4, Wk 8 | |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Raymond W Lam, MD, FRCPC | University of British Columbia | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of British Columbia, Department of Psychiatry | Vancouver | British Columbia | V6T 2A1 | Canada |
Not provided
| Label | URL |
|---|---|
| University of British Columbia | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Natural spring water with negligible lithium levels | Dietary Supplement | Oral intake of approximately 2 litres (2L) daily for 4 weeks |
|
| Change from Baseline in oxidative stress protein markers at 4 weeks |
Blood samples will be assayed for oxidative stress protein markers (superoxide dismutase, catalase, glutathione peroxidase, and TBARS) |
| Baseline, Wk 4, Wk 8 |